Elicio Therapeutics Inc. (ELTX)
NASDAQ · Healthcare
Elicio Therapeutics Inc. Cash on Hand 2020–2022
Elicio Therapeutics Inc. annual cash on hand history from 2020 to 2022. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Elicio Therapeutics Inc. cash on hand as of December 31, 2022: 6.2M, a 93.06% decrease year-over-year.
- Elicio Therapeutics Inc. cash on hand for 2022 were 6.2M, a 93.06% decrease from 2021.
- Elicio Therapeutics Inc. cash on hand for 2021 were 88.8M, a 156.47% increase from 2020.
- Elicio Therapeutics Inc. cash on hand for 2020 were 34.6M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Elicio Therapeutics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2022 | $6 |
| 2021 | $89 |
| 2020 | $35 |
Elicio Therapeutics Inc. Cash on Hand — FAQ
Elicio Therapeutics Inc. (ELTX) cash on hand over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ELTX's cash on hand history?
The chart and table above show Elicio Therapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.